Literature DB >> 2441840

Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex.

A A Sinha, M J Wilson, D F Gleason.   

Abstract

Human prostate specimens from 25 patients provided 15 normal, four benign prostatic hypertrophy (BPH), and seven adenocarcinoma samples which were studied using a polyclonal antibody against prostatic specific antigen (PSA) and protein A-gold complex. Our study showed the presence of gold particles in cytoplasmic vesicles and granules, rough endoplasmic reticulum, and occasional lysosomal dense bodies in columnar or cuboidal cells of acini from normal, BPH and well-differentiated cancerous specimens, but not in the acinar basal cells. Some moderately differentiated and most poorly differentiated tumors contained undifferentiated neoplastic cells in which PSA localizations often were associated with membranous structures since specific cytoplasmic organelles were not differentiated. In prostatic stroma, invasive cells which were of differentiated type localized gold particles. In addition, some neutrophils and macrophages also localized PSA suggesting their role in phagocytosis of extracellularly released PSA in the stroma of BPH and cancerous samples. Thus far, the authors have not observed neutrophils and macrophages with gold particles in normal prostate. We suggest that neutrophils and macrophages were involved in transport of some extracellularly released PSA from the prostatic stroma or other metastatic sites to sera in BPH and cancer patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441840     DOI: 10.1002/1097-0142(19870915)60:6<1288::aid-cncr2820600621>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  FHL2, a novel tissue-specific coactivator of the androgen receptor.

Authors:  J M Müller; U Isele; E Metzger; A Rempel; M Moser; A Pscherer; T Breyer; C Holubarsch; R Buettner; R Schüle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 2.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

3.  [Prostate cancer screening with a new marker based on circulating blood macrophages?].

Authors:  R Herwig; B Djavan; G Kramer; M A El-Taieb; F Kühhas; M Leers; M Marberger
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

4.  Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection.

Authors:  N L Simone; A T Remaley; L Charboneau; E F Petricoin; J W Glickman; M R Emmert-Buck; T A Fleisher; L A Liotta
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

5.  Identification of metastatic cell nucleus in human prostate cancer by electron microscopy.

Authors:  Akhouri A Sinha
Journal:  Future Sci OA       Date:  2020-07-07

6.  Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer.

Authors:  Scott D Cramer; Jielin Sun; S Lilly Zheng; Jianfeng Xu; Donna M Peehl
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

7.  Allelic variability in PSA & AR genes: a novel biomarker on the horizon for carcinoma prostate.

Authors:  P N Dogra
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.